STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G

XBIO Schedule 13G filing by Renaissance Technologies

Renaissance Technologies reported beneficial ownership of 178.5K shares, representing 7.79% of Xenetic Biosciences, Inc. in this filing.

FiledFeb 12, 2026
Ownership dateOct 27, 2025
Reported shares178.5K
Reported ownership7.79%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 178.5K
Shared voting power 0
Sole dispositive power 178.5K
Shared dispositive power 0
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$2.39as of Feb 12, 2026
Latest tracked price$2.85as of Aug 6, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Renaissance Technologies
CIK
CIK0001037389
Accession
0001037389-26-000022
Form
Schedule 13G
Open SEC filing View XBIO ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →